scholarly journals Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery

Nanoscale ◽  
2019 ◽  
Vol 11 (1) ◽  
pp. 219-236 ◽  
Author(s):  
Kenneth R. Sims ◽  
Yuan Liu ◽  
Geelsu Hwang ◽  
Hoi In Jung ◽  
Hyun Koo ◽  
...  

Novel polymer nanoparticle formulation improved drug loading, demonstrated zero-order release, and amplified anti-biofilm activity via increased bacterial membrane localization.

Lab on a Chip ◽  
2010 ◽  
Vol 10 (22) ◽  
pp. 3074 ◽  
Author(s):  
Daniel Fine ◽  
Alessandro Grattoni ◽  
Sharath Hosali ◽  
Arturas Ziemys ◽  
Enrica De Rosa ◽  
...  

2014 ◽  
Vol 3 (2) ◽  
pp. 153-153 ◽  
Author(s):  
Christian Celia ◽  
Silvia Ferrati ◽  
Shyam Bansal ◽  
Anne L. van de Ven ◽  
Barbara Ruozi ◽  
...  

2020 ◽  
Vol 24 ◽  
pp. 100953 ◽  
Author(s):  
Mrunalini Gaydhane ◽  
Pankaj Choubey ◽  
Chandra S. Sharma ◽  
Saptarshi Majumdar

Polymers ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 1769 ◽  
Author(s):  
Fabrizio Fina ◽  
Alvaro Goyanes ◽  
Martin Rowland ◽  
Simon Gaisford ◽  
Abdul W. Basit

Zero-order release formulations are designed to release a drug at a constant rate over a prolonged time, thus reducing systemic side effects and improving patience adherence to the therapy. Such formulations are traditionally complex to manufacture, requiring multiple steps. In this work, fused deposition modeling (FDM) 3D printing was explored to prepare on-demand printlets (3D printed tablets). The design includes a prolonged release core surrounded by an insoluble shell able to provide zero-order release profiles. The effect of drug loading (10, 25, and 40% w/w paracetamol) on the mechanical and physical properties of the hot melt extruded filaments and 3D printed formulations was evaluated. Two different shell 3D designs (6 mm and 8 mm diameter apertures) together with three different core infills (100, 50, and 25%) were prepared. The formulations showed a range of zero-order release profiles spanning 16 to 48 h. The work has shown that with simple formulation design modifications, it is possible to print extended release formulations with tunable, zero-order release kinetics. Moreover, by using different infill percentages, the dose contained in the printlet can be infinitely adjusted, providing an additive manufacturing route for personalizing medicines to a patient.


Author(s):  
Sining Li ◽  
Yaping Zhao

Abstract In this work, we reported preparation of melatonin-loaded zein nanoparticles using the technique of solution-enhanced dispersion by supercritical CO2 (SEDS) for prolonging the release of melatonin. The influence of pressure, temperature and the ratio of melatonin and zein on the morphology, the particle size and drug loading was investigated. The release profiles of the melatonin-loaded nanoparticles were evaluated. The sizes of the most particles were less than 100 nm at most conditions examined, and the morphology had three types: rod-like, globule, and filament. The maximum drug loading of 6.9% and encapsulation efficiencies of 80.2% were obtained, respectively, under different conditions. The release speed of the melatonin in the nanoparticles is lower than both the pure one and that in the physical mixture. It displayed a near zero-order release which implied that it could be applied as a potential controlled-release drug.


Author(s):  
Amit Singh ◽  
Deepa Pathak ◽  
Kamla Pathak

Secnidazole, a high dose antiprotozoal agent unstable at gastric pH was used as a model compound for deposition onto the adsorbent carriers by two methods namely solvent deposition and physical mixing for duodenal delivery. The drug/adsorbent systems were evaluated for pharmacotechnical properties and characterized by FT-IR, DSC, XRD, SEM and in vitro dissolution testing to investigate the influence of carriers and methods of preparation on in vitro drug release. The solvent deposited secnidazole adsorbates (F4-F6) with high drug loading capacity and better control on dissolution at all time points were subjected to modified release by encapsulating in formaldehyde treated PVP K40 coated capsules. The optimized formulation was able to maintain zero order release with a maximum release of 95.91% at the end of 8 h in contrast to marketed formulation that gave a burst release of 67.89% within 2.5 hours followed by a non zero order release of 87.89% at the end of fifth hour. Thus a formulation of secnidazole accurel adsorbates could be developed that when suitably designed provided controlled duodenal delivery.


Sign in / Sign up

Export Citation Format

Share Document